Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Toronto Stock Exchange  >  Cronos Group Inc    CRON   CA22717L1013

CRONOS GROUP INC

(CRON)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Toronto Stock Exchange
07/16/2019 07/17/2019 07/18/2019 07/19/2019 07/22/2019 Date
19.57(c) 19.61(c) 19.46(c) 19.52(c) 19.23(c) Last
501 613 478 137 436 779 472 637 522 649 Volume
+0.82% +0.20% -0.76% +0.31% -1.49% Change
More quotes
Financials (CAD)
Sales 2019 50,2 M
EBIT 2019 -38,5 M
Net income 2019 371 M
Finance 2019 2 389 M
Yield 2019 -
Sales 2020 177 M
EBIT 2020 19,4 M
Net income 2020 39,3 M
Finance 2020 2 412 M
Yield 2020 -
P/E ratio 2019 19,7x
P/E ratio 2020 1 923x
EV / Sales2019 81,2x
EV / Sales2020 22,9x
Capitalization 6 464 M
More Financials
Company
Cronos Group Inc is a Canada-based globally diversified and vertically integrated cannabis company with a worldwide presence. The Company operates through its subsidiaries and licensed producers: Peace Naturals Project Inc, which was the non-incumbent medical cannabis license granted by Health... 
Sector
Pharmaceuticals
Calendar
08/08Earnings Release
More about the company
Surperformance© ratings of Cronos Group Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on CRONOS GROUP INC
07/18Health Care up Amid Strong Earnings -- Health Care Roundup
DJ
07/11Cronos Group Enters Agreement to Acquire State-of-the-Art Fermentation and Ma..
GL
07/10GrowGeneration Names Former Home Depot CEO Nardelli as Senior Strategic Advis..
DJ
07/10Cannabis Startup Hires Ex-Kellogg Finance Chief -- WSJ
DJ
07/09Cannabis Startup Surterra Wellness Appoints Former Kellogg CFO as Finance Chi..
DJ
07/09Cronos Group Appoints Dr. Todd Abraham as Chief Innovation Officer
GL
07/08Cronos Group Inc. to Hold Second Quarter 2019 Earnings Conference Call
GL
07/08Ontario's slow rollout of weed outlets could help black market
RE
06/19Cronos Group Inc. Announces Results of Vote for Election of Directors
GL
05/30Cronos Group Inc. to Present at Piper Jaffray 39th Annual Consumer Marketplac..
GL
More news
Analyst Recommendations on CRONOS GROUP INC
More recommendations
Sector news : Alternative Medicine
12:38pGLAXOSMITHKLINE : ViiV Healthcare Finds Positive Data In HIV Drug Study
DJ
12:04pBAYER : Iberogast Drug Is Safe
DJ
11:22aFDA Approves Multiple Applications for Generic Version of Lyrica
DJ
10:43aALLERGAN : Form 8.3 -
DJ
10:18aMERCK AND : Bayer sells Dr. Scholl's footcare brand to Yellow Wood Partners
RE
More sector news : Alternative Medicine
Chart CRONOS GROUP INC
Duration : Period :
Cronos Group Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CRONOS GROUP INC
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Average target price 19,50  CAD
Last Close Price 19,23  CAD
Spread / Highest target 35,2%
Spread / Average Target 1,40%
Spread / Lowest Target -24,6%
EPS Revisions
Managers
NameTitle
Michael Gorenstein Chairman, President & Chief Executive Officer
David Hsu Chief Operating Officer
William Hilson Chief Financial Officer
Alan Friedman Independent Director
Jason M. Adler Director
Sector and Competitors
1st jan.Capitalization (M$)
CRONOS GROUP INC35.74%5 018
CANOPY GROWTH CORP26.52%12 249
AURORA CANNABIS INC31.56%6 936
BEIJING TONGRENTANG CO., LTD.4.98%5 756
DONG-E-E-JIAO CO LTD--.--%3 122
APHRIA INC0.00%1 608